NEW YORK, June 17, 2024 /PRNewswire/ — Ernst & Young LLP (EY US) The recent EY Health Pulse Survey reveals that technology advancements are enhancing member engagement and access to health care services. The increased engagement is translating into tangible improvements in care. Executives report that members are expressing a heightened sense of control over their health management, encountering fewer obstacles when seeking health information, experiencing lower nonpayment rates and expressing greater overall satisfaction with their health care.
“Integrating consumer-oriented technology into health care processes connects members to personalized care, empowers them with real-time health insights and creates more effective and efficient care and administrative experiences,” said Abby Johnson, EY Americas Health Consulting Leader. “It’s the bridge between traditional practice and a future where members hold the key to their own wellbeing, with the support of data-driven, accessible and compassionate health care solutions.”
Personalization and access increase member satisfaction and decrease wait times
Wearable devices give real-time aid and data
Continuous measurement evolves data and tech improvement
“Nearly four out of five insurance leaders acknowledge that telehealth has not only bridged the distance between members and providers but has also made health care more affordable for members,” said Kaushik Bhaumik, EY US Health Technology Leader. “Meanwhile, improved interoperability using digital tools is not just a matter of convenience: It’s a financial and regulatory imperative, with over a third of these executives citing it as a key factor in reducing nonpayment rates. Together, these advancements are shaping a more efficient, accessible and sustainable health care system for all.”
Cybersecurity investments boost compliance and member trust
Cybersecurity has become a critical focus, with more than half of executives reporting increased investment in cybersecurity solutions compared with last year. While escalating costs are a concern, financial commitment appears to be yielding positive results and consumer confidence.
Poll methodology: EY US commissioned Atomik Research to conduct an online survey of 56 health insurance company executives who are involved with digital health within their organizations. Qualifying executives held titles such as director or higher and were employed full time at organizations with 5,000 or more employees. Fieldwork took place between April 19, 2024 through May 6, 2024. Atomik Research is a creative market research agency.
About EY
EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets.
Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate.
Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.
Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited operating in the US.
Contact:
Carol Piering
carol.piering@ey.com
SOURCE EY
Parenting is a hard job under the best of circumstances. It can be especially confusing…
HUNTSVILLE, AL / ACCESSWIRE / June 19, 2024 / Curiteva, Inc., a leading technology and…
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. ("Theralase®" or the…
ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that…
Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people…
LOS ANGELES, June 19, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the…